Other Free Encyclopedias » Medicine Encyclopedia » Aging Healthy - Part 1 » Alzheimer's Disease - Clinical Presentation, Diagnosis, Pathophysiology, Treatments, Conclusion

Alzheimer's Disease - Conclusion

aging genetic clinical dementia neurology journal gauthier

Although the human and societal cost of AD is staggering, there is hope that earlier and better diagnosis, increased knowledge of its natural history with support of the patient and family throughout the disease stages, effective symptomatic drugs, and potentially effective disease modification strategies will have a dramatic impact on the number of persons affected in the future, and the quality of life of persons currently affected. The fast pace of research and development in AD is unique in neurological history, and should lead to a better future for aging populations.

SERGE GAUTHIER

BIBLIOGRAPHY

BREINTNER, J. C. S. "The End of Alzheimer's Disease?" International Journal of Geriatric Psychiatry 14 (1999): 577–586.

GAUTHIER, S. Alzheimer's Disease in Primary Care, 2d ed. Martin Dunitz, 1999.

GAUTHIER, S. "Managing Expectations in the Long-Term Treatment of Alzheimer's Disease." Gerontology 45 (1999): 33–38.

MAYEUX, R., and SANO, M. "Treatment of Alzheimer's Disease." New England Journal of Medicine 341 (1999): 1670–1679.

MCKHANN, G.; DRACHMAN, D.; FOLSTEIN, M.; KATZMAN, R.; PRICE, D.; and STADLAN, E. M. "Clinical Diagnosis of Alzheimer's Disease: Report of the NINCDS-ADRDA Work Group Under the Auspices of Department of Health and Human Services Task Force on Table 6 Testable hypothesis to delay onset or progression of Alzheimer's disease SOURCE: Author Alzheimer's Disease." Neurology 24 (1984): 939–944.

MEGEER, P.; SCHULZER, M.; and MCGEER, E. "Arthritis and Anti-Inflammatory Agents As Possible Protective Factors for Alzheimer's Disease: A Review of 17 Epidemiological Studies." Neurology 47 (1996): 425–432.

REISBERG, B.; FERRIS, S. H.; DE LEON, M. J.; and CROOK, T. "The Global Deterioration Scale for Assessment of Primary Degenerative Dementia." American Journal of Psychiatry 139 (1982): 1136–1139.

ROSENBERG, R. N. "The Molecular and Genetic Basis of AD: The End of the Beginning." Neurology 54 (2000): 2045–2054.

TERRY, R. D.; MASLIAH, E. E.; SALMON, D. P.; BUTTERS, N.; DETERESA, R.; HILL, R.; HANSEN, L. A.; and KATZMAN, R. "Physical Basis of Cognitive Alterations in Alzheimer's Disease: Synapse Loss is the Major Correlate of Cognitive Impairment." Annals of Neurology 30 (1991): 572–580.

THAL, L. "Potential Prevention Strategies for Alzheimer's Disease." Alzheimer Disease and Associated Disorders 10, suppl. 1 (1996): 6–8.

WHITEHOUSE, P.; PRICE, D. L.; CLARK, A. W.; COYLE, J. T.; and DELONG, M. R. "Alzheimer Disease: Evidence for Selective Loss of Cholinergic Neurons in the Nucleus Basalis." Annals of Neurology 10 (1981): 122–126.

[back] Alzheimer's Disease - Treatments

User Comments

The following comments are not guaranteed to be that of a trained medical professional. Please consult your physician for advice.

Your email address will be altered so spam harvesting bots can't read it easily.
Hide my email completely instead?

Cancel or

Vote down Vote up

almost 7 years ago

conclusion for alzheimer's disease

Vote down Vote up

almost 2 years ago

LOVVVVVVVVVVVVVVVVVVVVVVVVEEEEEEEEEEEEEEEEEEEEE!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

Vote down Vote up

almost 2 years ago

this is maybe good but not good for a conclusion i asked for a conclusion not this stupids and you are a blow head useless piece or work. I don't like this its boring make it more interesting please.